Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
SINT 
SINTX Technologies Inc (SINT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: SINT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $28
1 Year Target Price $28
| 1 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -35.25% | Avg. Invested days 8 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 8.31M USD | Price to earnings Ratio - | 1Y Target Price 28 |
Price to earnings Ratio - | 1Y Target Price 28 | ||
Volume (30-day avg) 2 | Beta 0.65 | 52 Weeks Range 1.71 - 8.60 | Updated Date 08/15/2025 |
52 Weeks Range 1.71 - 8.60 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.9 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-04 | When After Market | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -631.98% |
Management Effectiveness
Return on Assets (TTM) -30.78% | Return on Equity (TTM) -155.2% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 5531839 | Price to Sales(TTM) 3.24 |
Enterprise Value 5531839 | Price to Sales(TTM) 3.24 | ||
Enterprise Value to Revenue 4.5 | Enterprise Value to EBITDA -0.56 | Shares Outstanding 2725920 | Shares Floating 2021039 |
Shares Outstanding 2725920 | Shares Floating 2021039 | ||
Percent Insiders 11.71 | Percent Institutions 6.63 |
Upturn AI SWOT
SINTX Technologies Inc
Company Overview
History and Background
SINTX Technologies, Inc. (formerly Ceramatec, Inc. and Active Protective Technologies, Inc.) was founded in 2008. It focuses on developing and commercializing silicon nitride for various applications, particularly in biomedical and industrial sectors. Over time, it has evolved from materials research to a company with a portfolio of patents and products.
Core Business Areas
- Biomedical: Development and commercialization of silicon nitride-based medical devices and coatings, including spinal implants and antimicrobial coatings. Focus is on orthopedic and dental applications.
- Industrial: Applications of silicon nitride in high-performance industrial components, such as wear-resistant parts and bearings. Potential for oil and gas, aerospace, and automotive industries.
Leadership and Structure
The leadership team includes key executives in finance, research, and operations. The organizational structure is typically hierarchical with functional departments reporting to the executive management.
Top Products and Market Share
Key Offerings
- Spinal Implants: Silicon nitride spinal implants offering improved biocompatibility and bone fusion compared to traditional materials like titanium. Market share is small but growing. Competitors include Medtronic (MDT), Johnson & Johnson (JNJ), and Stryker (SYK). Exact market share data is difficult to source due to the fragmented nature of the spinal implant market. Recent reports suggest a growth potential in advanced biomaterials within this sector.
- Antimicrobial Coatings: Silicon nitride-based antimicrobial coatings for medical devices and other applications. Market share is limited due to the emerging nature of the technology. Competitors include companies offering silver-based and other antimicrobial coatings.
Market Dynamics
Industry Overview
The medical device industry is highly regulated and competitive, with a growing demand for advanced materials and biocompatible solutions. The industrial ceramics market is also growing, driven by demand for high-performance materials in various applications.
Positioning
SINTX Technologies is positioned as a materials science company specializing in silicon nitride. Its competitive advantage lies in the unique properties of its silicon nitride formulations, offering improved biocompatibility, antimicrobial properties, and mechanical strength.
Total Addressable Market (TAM)
The TAM for silicon nitride in biomedical and industrial applications is estimated to be in the billions of dollars. SINTX is positioned to capture a portion of this market by focusing on niche applications and developing innovative products.
Upturn SWOT Analysis
Strengths
- Proprietary silicon nitride technology
- Strong intellectual property portfolio
- Potential for improved biocompatibility and antimicrobial properties
- Growing market demand for advanced biomaterials
Weaknesses
- Limited market presence and brand recognition
- Dependence on key patents
- High research and development costs
- History of financial losses
Opportunities
- Expanding applications in spinal implants and other medical devices
- Partnerships with medical device manufacturers
- Entering new industrial markets
- Increasing awareness of silicon nitride benefits
Threats
- Competition from established medical device companies
- Regulatory hurdles
- Patent infringement
- Economic downturn
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- SYK
Competitive Landscape
SINTX is at a distinct competitive disadvantage compared to its well-established larger competitors who have deeper pockets and established distribution networks. The company is trying to compete through novel biomaterial products.
Growth Trajectory and Initiatives
Historical Growth: Growth has been slow due to regulatory hurdles and commercialization challenges.
Future Projections: Analysts' estimates vary, but suggest that there is potential for revenue growth as products gain market acceptance. However, the company needs to become profitable to achieve sustainable growth.
Recent Initiatives: Recent initiatives include expanding the product portfolio, seeking regulatory approvals, and pursuing partnerships.
Summary
SINTX Technologies is an early-stage company with innovative silicon nitride technology. It faces challenges in commercializing its products and achieving profitability. The key to future success involves further development, regulatory approval, and strategic partnerships to overcome competition.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SINTX Technologies Inc. SEC Filings
- Industry Reports
- Analyst Reports
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Investment decisions should be based on your own research and due diligence. Market data is approximate and subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SINTX Technologies Inc
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2014-02-13 | President, CEO & Chairman of the Board Mr. Eric K. Olson | ||
Sector Healthcare | Industry Medical Devices | Full time employees 20 | Website https://www.sintx.com |
Full time employees 20 | Website https://www.sintx.com | ||
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.